In 2014, the new term genitourinary syndrome of menopause (GSM) was introduced to encompass the symptoms associated with the loss of estrogen that occurs with menopause. These symptoms of atrophy affect the vulva, vagina, bladder and urethra. Patients can experience symptoms such as pain, sexual dysfunction, vaginal bleeding and recurrent urinary tract infections. In addition to vaginal estrogen, we review the non-estrogen medications and in-office procedures available to treat GSM.
Continuing Education Instructions and Disclosure Information
Contact hours available until 10/28/2020.
Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online CNE evaluation. You will be able to print your CNE certificate at any time after you complete the evaluation.
Planning Committee Disclosures: Heather Schultz, MSN, RN, NP-C - AUA Leadership Position 2018 Program Planner
Speakers Conflict of Interest Disclosure: There are no disclosures to declare.
Commercial Support and Sponsorship:
No commercial support or sponsorship declared.
The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of continuing nursing education by the American Nurses’ Credentialing Center’s Commission on Accreditation.
The SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is also a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of CE in nursing does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the CE requirements for re-licensure in the states in which they hold a license.
After completing this continuing nursing education activity the learner will be able to describe estrogen and non-estrogen therapies to treat genitourinary syndrome of menopause.